AFFiRiS’ Advertisement02 Alzheimer’s vaccine applicant in phase II clinical testing AFFiRiS AG’s clinical Alzheimer’s vaccine candidate Advertisement02 has already progressed to stage II clinical assessment. It may therefore be possible to confirm the efficacy of the vaccine as soon as during 2012. Certainly the start of this efficacy research comes only five a few months following the completion of the corresponding stage I study sildenafil 100 mg . The company is active in a number of disease areas and is currently developing a total of twelve prospective products in all stages of the development pipeline up to clinical phase II. The prospective Alzheimer’s vaccine AD02 by AFFiRiS AG will with instant effect be used in a multicentre phase II clinical research in Austria and five other European countries.
This is actually the largest donation we have received to date and we are thankful for the support, said Chris Angelo Word, founder of Lifedriven Base. Lifedriven provides helped over 100 local households and is normally filming a documentary currently, traveling around the united states to raise $1 million to benefit children experiencing cancer. Through the initiatives of Mitra Heshmatpour, we are committed to helping this wonderful regional firm lift the spirits of kids, said Amir Heshmatpour, Managing Director of AFH Keeping & Advisory. Dealing with entrepreneurs as I really do, I understand how valuable unique ideas could be in the hands of inspirational leaders such as Chris Angelo Word.